Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Theravance Biopharma, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 119 | 114 | −5 |
| Shares | 62.1M | 60.2M | −1.91M (−3.1%) |
| Value | $696.1M | $652.6M | −$43.5M (−6.2%) |
New holders (10)
Institutions that held Theravance Biopharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Arkadios Wealth Advisors | 24,669 | $267.7K | 0.03% |
| Aigen Investment Management, LP | 23,719 | $257.4K | 0.04% |
| Cantor Fitzgerald, L. P. | 20,000 | $217.0K | 0.00% |
| Graham Capital Management, L.P. | 17,930 | $194.5K | 0.01% |
| Prudential Financial Inc | 15,785 | $171.3K | 0.00% |
| Teacher Retirement System of Texas | 15,565 | $169.0K | 0.00% |
| Mariner, LLC | 10,339 | $112.0K | 0.00% |
| Group One Trading, L.P. | 3,612 | $39.2K | 0.00% |
| Allworth Financial LP | 106 | $1.15K | 0.00% |
| Pacific Center for Financial Services | 57 | $619 | 0.00% |
Sold out (15)
Institutions that held Theravance Biopharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Renaissance Technologies LLC | 176,426 | $1.98M |
| Victory Capital Management Inc | 158,470 | $1.78M |
| Cubist Systematic Strategies, LLC | 151,440 | $1.70M |
| Saturn V Capital Management LLC | 141,339 | $1.33M |
| Putnam Investments LLC | 102,102 | $1.15M |
| Palliser Capital (UK) Ltd | 97,100 | $1.09M |
| Caption Management, LLC | 82,000 | $920.0K |
| Jump Financial, LLC | 49,800 | $558.8K |
| Occudo Quantitative Strategies LP | 43,321 | $486.1K |
| Schonfeld Strategic Advisors LLC | 29,160 | $327.2K |
| Trexquant Investment LP | 18,705 | $209.9K |
| AXA S.A. | 13,700 | $153.7K |
| Verition Fund Management LLC | 11,261 | $126.3K |
| Point72 Middle East FZE | 3,649 | $40.9K |
| Lindbrook Capital, LLC | 132 | $1.48K |